HF
RNTX

HRT Financial’s Rein Therapeutics RNTX Stock Holding History

HRT Financial’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,486
Closed -$20K – 5646
2026
Q1 		$20K Sell
15,486
-17,751
-53% -$22K ﹤0.01% 3577
2025
Q4 		$38K Buy
+33,237
New +$45.8K ﹤0.01% 2914
2023
Q2 		– Sell
-11,671
Closed -$14K – 3432
2023
Q1 		$14K Buy
+11,671
New +$25K ﹤0.01% 2222
2022
Q1 		– Sell
-532
Closed -$5K – 4018
2021
Q4 		$5K Sell
532
-433
-45% -$6.7K ﹤0.01% 3053
2021
Q3 		$19K Buy
+965
New +$21.1K ﹤0.01% 3146

Other funds holding RNTX

VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

HRT Financial's RNTX Position: Q2 2026 in Review

HRT Financial sold out of Rein Therapeutics (RNTX) in Q2 2026, closing a stake of 15,486 shares — an estimated $20K sold.

HRT Financial first reported a position in RNTX in Q3 2021 and held it in 5 quarters. The position peaked at $38K in Q4 2025. 60 funds tracked by Wall St. Rank hold RNTX as of Q2 2026.

  • HRT Financial reported no remaining Rein Therapeutics position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 15,486 Rein Therapeutics shares in Q2 2026, an estimated $20K.
  • HRT Financial first reported a position in Rein Therapeutics in Q3 2021 and held it in 5 quarters.
  • HRT Financial's Rein Therapeutics position peaked at $38K in Q4 2025.
  • 60 funds tracked by Wall St. Rank held Rein Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.